Former pharmaceutical CEO Martin Shkreli says he’d like to “berate” and “insult” Congress—but instead will take the Fifth Amendment during questioning on Thursday.

The former Turing Pharmaceuticals CEO, who’s known for hiking the price of a lifesaving drug, spoke Tuesday on Fox Business.

Shkreli said that instead of invoking his right against self-incrimination, as planned, he would “love to talk to Congress.” He says he would “berate them” and “insult them.”

Meanwhile, his new lawyer, Benjamin Brafman, issued a statement expressing confidence that Shkreli will be exonerated in his federal court case. He’ll have a routine court appearance Wednesday in New York.

In December, the former hedge fund manager was charged with securities fraud and conspiracy related to another pharmaceutical company he previously ran, Retrophin.

Lead image photo credit: Lawrence Jackson.

Follow us on Twitter and Facebook for updates on the latest pharmaceutical and biopharmaceutical manufacturing news!